Dynamics of HCV hypervariable region 1 (HVR1) quasispecies in chimpanzees during chronic hcv infection and effect of passive transfer of anti-HCV immunoglobulin.

被引:0
作者
Kamili, SE
Li, XF
Abubaker, R
Farci, P
Spelbring, J
Carson, D
Fattom, A
Naso, R
Krawczynski, K
机构
[1] NCID, Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA
[2] Univ Cagliari, I-09124 Cagliari, Italy
[3] Nabi, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1092
引用
收藏
页码:445A / 445A
页数:1
相关论文
共 50 条
  • [21] Genetic characterization of hypervariable region 1 (HVR1) quasispecies changes during interferon (IFN)-α therapy in patients with chronic hepatitis C.
    Pawlotsky, JM
    Germanidis, G
    Frainais, PO
    Bouvier, M
    Dhumeaux, D
    HEPATOLOGY, 1998, 28 (04) : 289A - 289A
  • [22] Molecular analysis of HCV E1E2 envelope region during experimental HCV infection in chimpanzees.
    Kamili, S
    Li, XF
    Fattom, A
    Sapan, C
    Krawczynski, K
    HEPATOLOGY, 2004, 40 (04) : 440A - 441A
  • [23] DELETION OF HYPERVARIABLE REGION 1 (HVR1) OF E2 FROM HCV GENOTYPES 1-6 HAS DIFFERENTIAL EFFECT ON INFECTIVITY IN VITRO AND CAUSES INCREASED SUSCEPTIBILITY TO NEUTRALIZATION
    Prentoe, J.
    Gottwein, J. M.
    Scheel, T. K. H.
    Jensen, T. B.
    Serre, S.
    Bukh, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S34 - S34
  • [24] Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation
    Sánchez-Fueyo, A
    Giménez-Barcons, M
    Puig-Basagoiti, F
    Rimola, A
    Sánchez-Tapias, JM
    Sáiz, JC
    Rodés, J
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) : 266 - 275
  • [25] HCV infection of the transplanted liver: Changing CD81 and HVR1 variants immediately after liver transplantation
    Hughes, MG
    Chong, TW
    Smith, RL
    Evans, HL
    Iezzoni, JC
    Sawyer, RG
    Rudy, CK
    Pruett, TL
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2504 - 2513
  • [26] Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period
    Barcena, Rafael
    Moreno, Ana
    Angel Rodriguez-Gandia, Miguel
    Albillos, Agustin
    Arocena, Carlos
    Blesa, Carlos
    Garcia-Hoz, Fernando
    Graus, Javier
    Nuno, Javier
    Lopez-Hervas, Pedro
    Gajate, Luis
    Martinez, Adolfo
    Bermejo, Teresa
    Luisa Mateos, Maria
    del Campo, Santos
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 421 - 426
  • [27] The prediction of interferon-α therapeutic effect by sequence variation of the HCV hypervariable region 1
    Yeh, BI
    Kim, HW
    Kim, HS
    Lee, JY
    Lee, KH
    Lee, KM
    Kim, JS
    Han, KH
    YONSEI MEDICAL JOURNAL, 1999, 40 (05) : 430 - 438
  • [28] Genetic evolution of hypervariable region 1 (HVRI) during the course of acute hepatitis C suggests that HVRI is not the principal target for anti-HCV neutralizing responses
    Morice, Y
    Brillet, R
    Lavillette, D
    Penin, F
    Donot, P
    Germanidis, G
    Soulier, A
    Pagkalos, E
    Sakellariou, G
    Cosset, FL
    Pawlotsky, JM
    JOURNAL OF HEPATOLOGY, 2005, 42 : 21 - 21
  • [29] Safety and anti-HCV Effect of Prolonged Intravenous Silibinin in HCV-Genotype 1 Subjects in the Immediate Liver Transplant Period
    Barcena, Rafael
    Rodriguez-Gandia, Miguel A.
    Moreno, Ana
    Albillos, Agustin
    Arocena, Carlos
    Blesa, Carlos
    Garcia-Hoz, Fernando
    Graus, Javier
    Nuno, Javier
    Lopez Hervas, Pedro
    Gajate, Luis
    Martinez, Adolfo
    Bermejo, Teresa
    Mateos, Maria L.
    del Campo, Santos
    HEPATOLOGY, 2012, 56 : 296A - 297A
  • [30] Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain
    Sugitani, M.
    Nishimura, S.
    Mizuno, K.
    Shikata, T.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2010, 39 (01) : 1 - 8